Allworth Financial LP Keros Therapeutics, Inc. Put Options Transaction History
Allworth Financial LP
- $17.4 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding KROS
# of Institutions
168Shares Held
31.3MCall Options Held
646KPut Options Held
670K-
Vanguard Group Inc Valley Forge, PA2.57MShares$37.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.51MShares$36.6 Million0.0% of portfolio
-
Braidwell LP Stamford, CT1.89MShares$27.6 Million1.68% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y91.69MShares$24.6 Million2.53% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.22MShares$17.8 Million0.03% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $375M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...